 | • レポートコード：GIR-105X12395 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ネオマイシンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ネオマイシンの種類別市場規模（98％純度、95％純度、その他）、用途別市場規模（ネオマイシン硫酸塩点眼薬、ネオマイシン硫酸塩錠剤、化合物ネオマイシン軟膏）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ネオマイシンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Angene、Aba Chem Scene、MuseChem、Biosynth、DC Chemicals、Chem Strong、Yuanye Biology、Weibo ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：98％純度、95％純度、その他 ・用途別分析2016年-2026年：ネオマイシン硫酸塩点眼薬、ネオマイシン硫酸塩錠剤、化合物ネオマイシン軟膏 ・ネオマイシンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ネオマイシンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ネオマイシンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ネオマイシンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ネオマイシンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Neomycin (CAS 119-04-0) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Neomycin (CAS 119-04-0) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Neomycin (CAS 119-04-0) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Neomycin (CAS 119-04-0) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
98% Purity Type
95% Purity Type
Others
Market segment by Application can be divided into
Neomycin Sulfate Eye Drops
Neomycin Sulfate Tablets
Compound Neomycin Ointment
The key market players for global Neomycin (CAS 119-04-0) market are listed below:
Angene
Aba Chem Scene
MuseChem
Biosynth
DC Chemicals
Chem Strong
Yuanye Biology
Weibo
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Neomycin (CAS 119-04-0) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neomycin (CAS 119-04-0) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 98% Purity Type
1.2.3 95% Purity Type
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Neomycin (CAS 119-04-0) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Neomycin Sulfate Eye Drops
1.3.3 Neomycin Sulfate Tablets
1.3.4 Compound Neomycin Ointment
1.4 Global Neomycin (CAS 119-04-0) Market Size & Forecast
1.4.1 Global Neomycin (CAS 119-04-0) Sales in Value (2016-2026))
1.4.2 Global Neomycin (CAS 119-04-0) Sales in Volume (2016-2026)
1.4.3 Global Neomycin (CAS 119-04-0) Price by Type (2016-2026) & (USD/Kg)
1.5 Global Neomycin (CAS 119-04-0) Production Capacity Analysis
1.5.1 Global Neomycin (CAS 119-04-0) Total Production Capacity (2016-2026)
1.5.2 Global Neomycin (CAS 119-04-0) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neomycin (CAS 119-04-0) Market Drivers
1.6.2 Neomycin (CAS 119-04-0) Market Restraints
1.6.3 Neomycin (CAS 119-04-0) Trends Analysis
2 Manufacturers Profiles
2.1 Angene
2.1.1 Angene Details
2.1.2 Angene Major Business
2.1.3 Angene Neomycin (CAS 119-04-0) Product and Services
2.1.4 Angene Neomycin (CAS 119-04-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Aba Chem Scene
2.2.1 Aba Chem Scene Details
2.2.2 Aba Chem Scene Major Business
2.2.3 Aba Chem Scene Neomycin (CAS 119-04-0) Product and Services
2.2.4 Aba Chem Scene Neomycin (CAS 119-04-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 MuseChem
2.3.1 MuseChem Details
2.3.2 MuseChem Major Business
2.3.3 MuseChem Neomycin (CAS 119-04-0) Product and Services
2.3.4 MuseChem Neomycin (CAS 119-04-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Biosynth
2.4.1 Biosynth Details
2.4.2 Biosynth Major Business
2.4.3 Biosynth Neomycin (CAS 119-04-0) Product and Services
2.4.4 Biosynth Neomycin (CAS 119-04-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 DC Chemicals
2.5.1 DC Chemicals Details
2.5.2 DC Chemicals Major Business
2.5.3 DC Chemicals Neomycin (CAS 119-04-0) Product and Services
2.5.4 DC Chemicals Neomycin (CAS 119-04-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Chem Strong
2.6.1 Chem Strong Details
2.6.2 Chem Strong Major Business
2.6.3 Chem Strong Neomycin (CAS 119-04-0) Product and Services
2.6.4 Chem Strong Neomycin (CAS 119-04-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Yuanye Biology
2.7.1 Yuanye Biology Details
2.7.2 Yuanye Biology Major Business
2.7.3 Yuanye Biology Neomycin (CAS 119-04-0) Product and Services
2.7.4 Yuanye Biology Neomycin (CAS 119-04-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Weibo
2.8.1 Weibo Details
2.8.2 Weibo Major Business
2.8.3 Weibo Neomycin (CAS 119-04-0) Product and Services
2.8.4 Weibo Neomycin (CAS 119-04-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Neomycin (CAS 119-04-0) Sales by Manufacturer
3.1 Global Neomycin (CAS 119-04-0) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Neomycin (CAS 119-04-0) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Neomycin (CAS 119-04-0)
3.4 Market Concentration Rate
3.4.1 Top 3 Neomycin (CAS 119-04-0) Manufacturer Market Share
3.4.2 Top 6 Neomycin (CAS 119-04-0) Manufacturer Market Share
3.5 Global Neomycin (CAS 119-04-0) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Neomycin (CAS 119-04-0) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Neomycin (CAS 119-04-0) Market Size by Region
4.1.1 Global Neomycin (CAS 119-04-0) Sales in Volume by Region (2016-2026)
4.1.2 Global Neomycin (CAS 119-04-0) Revenue by Region (2016-2026)
4.2 North America Neomycin (CAS 119-04-0) Revenue (2016-2026)
4.3 Europe Neomycin (CAS 119-04-0) Revenue (2016-2026)
4.4 Asia-Pacific Neomycin (CAS 119-04-0) Revenue (2016-2026)
4.5 South America Neomycin (CAS 119-04-0) Revenue (2016-2026)
4.6 Middle East and Africa Neomycin (CAS 119-04-0) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Neomycin (CAS 119-04-0) Sales in Volume by Type (2016-2026)
5.2 Global Neomycin (CAS 119-04-0) Revenue by Type (2016-2026)
5.3 Global Neomycin (CAS 119-04-0) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Neomycin (CAS 119-04-0) Sales in Volume by Application (2016-2026)
6.2 Global Neomycin (CAS 119-04-0) Revenue by Application (2016-2026)
6.3 Global Neomycin (CAS 119-04-0) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Neomycin (CAS 119-04-0) Sales by Type (2016-2026)
7.2 North America Neomycin (CAS 119-04-0) Sales by Application (2016-2026)
7.3 North America Neomycin (CAS 119-04-0) Market Size by Country
7.3.1 North America Neomycin (CAS 119-04-0) Sales in Volume by Country (2016-2026)
7.3.2 North America Neomycin (CAS 119-04-0) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Neomycin (CAS 119-04-0) Sales by Type (2016-2026)
8.2 Europe Neomycin (CAS 119-04-0) Sales by Application (2016-2026)
8.3 Europe Neomycin (CAS 119-04-0) Market Size by Country
8.3.1 Europe Neomycin (CAS 119-04-0) Sales in Volume by Country (2016-2026)
8.3.2 Europe Neomycin (CAS 119-04-0) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Neomycin (CAS 119-04-0) Sales by Type (2016-2026)
9.2 Asia-Pacific Neomycin (CAS 119-04-0) Sales by Application (2016-2026)
9.3 Asia-Pacific Neomycin (CAS 119-04-0) Market Size by Region
9.3.1 Asia-Pacific Neomycin (CAS 119-04-0) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Neomycin (CAS 119-04-0) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Neomycin (CAS 119-04-0) Sales by Type (2016-2026)
10.2 South America Neomycin (CAS 119-04-0) Sales by Application (2016-2026)
10.3 South America Neomycin (CAS 119-04-0) Market Size by Country
10.3.1 South America Neomycin (CAS 119-04-0) Sales in Volume by Country (2016-2026)
10.3.2 South America Neomycin (CAS 119-04-0) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Neomycin (CAS 119-04-0) Sales by Type (2016-2026)
11.2 Middle East & Africa Neomycin (CAS 119-04-0) Sales by Application (2016-2026)
11.3 Middle East & Africa Neomycin (CAS 119-04-0) Market Size by Country
11.3.1 Middle East & Africa Neomycin (CAS 119-04-0) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Neomycin (CAS 119-04-0) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Neomycin (CAS 119-04-0) Typical Distributors
12.3 Neomycin (CAS 119-04-0) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Neomycin (CAS 119-04-0) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Neomycin (CAS 119-04-0) Revenue by Application, (USD Million), 2021-2026
Table 3. Angene Basic Information, Manufacturing Base and Competitors
Table 4. Angene Major Business
Table 5. Angene Neomycin (CAS 119-04-0) Product and Services
Table 6. Angene Neomycin (CAS 119-04-0) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Aba Chem Scene Basic Information, Manufacturing Base and Competitors
Table 8. Aba Chem Scene Major Business
Table 9. Aba Chem Scene Neomycin (CAS 119-04-0) Product and Services
Table 10. Aba Chem Scene Neomycin (CAS 119-04-0) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. MuseChem Basic Information, Manufacturing Base and Competitors
Table 12. MuseChem Major Business
Table 13. MuseChem Neomycin (CAS 119-04-0) Product and Services
Table 14. MuseChem Neomycin (CAS 119-04-0) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Biosynth Basic Information, Manufacturing Base and Competitors
Table 16. Biosynth Major Business
Table 17. Biosynth Neomycin (CAS 119-04-0) Product and Services
Table 18. Biosynth Neomycin (CAS 119-04-0) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. DC Chemicals Basic Information, Manufacturing Base and Competitors
Table 20. DC Chemicals Major Business
Table 21. DC Chemicals Neomycin (CAS 119-04-0) Product and Services
Table 22. DC Chemicals Neomycin (CAS 119-04-0) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Chem Strong Basic Information, Manufacturing Base and Competitors
Table 24. Chem Strong Major Business
Table 25. Chem Strong Neomycin (CAS 119-04-0) Product and Services
Table 26. Chem Strong Neomycin (CAS 119-04-0) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Yuanye Biology Basic Information, Manufacturing Base and Competitors
Table 28. Yuanye Biology Major Business
Table 29. Yuanye Biology Neomycin (CAS 119-04-0) Product and Services
Table 30. Yuanye Biology Neomycin (CAS 119-04-0) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Weibo Basic Information, Manufacturing Base and Competitors
Table 32. Weibo Major Business
Table 33. Weibo Neomycin (CAS 119-04-0) Product and Services
Table 34. Weibo Neomycin (CAS 119-04-0) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Neomycin (CAS 119-04-0) Sales by Manufacturer (2019-2021e) & (Kg)
Table 36. Global Neomycin (CAS 119-04-0) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Neomycin (CAS 119-04-0), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Neomycin (CAS 119-04-0) Production Capacity by Company, (Kg): 2020 VS 2021
Table 39. Head Office and Neomycin (CAS 119-04-0) Production Site of Key Manufacturer
Table 40. Global Neomycin (CAS 119-04-0) Sales by Region (2016-2021e) & (Kg)
Table 41. Global Neomycin (CAS 119-04-0) Sales by Region (2021-2026) & (Kg)
Table 42. Global Neomycin (CAS 119-04-0) Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Neomycin (CAS 119-04-0) Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Neomycin (CAS 119-04-0) Sales by Type (2016-2021e) & (Kg)
Table 45. Global Neomycin (CAS 119-04-0) Sales by Type (2021-2026) & (Kg)
Table 46. Global Neomycin (CAS 119-04-0) Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Neomycin (CAS 119-04-0) Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Neomycin (CAS 119-04-0) Price by Type (2016-2021e) & (USD/Kg)
Table 49. Global Neomycin (CAS 119-04-0) Price by Type (2021-2026) & (USD/Kg)
Table 50. Global Neomycin (CAS 119-04-0) Sales by Application (2016-2021e) & (Kg)
Table 51. Global Neomycin (CAS 119-04-0) Sales by Application (2021-2026) & (Kg)
Table 52. Global Neomycin (CAS 119-04-0) Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Neomycin (CAS 119-04-0) Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Neomycin (CAS 119-04-0) Price by Application (2016-2021e) & (USD/Kg)
Table 55. Global Neomycin (CAS 119-04-0) Price by Application (2021-2026) & (USD/Kg)
Table 56. North America Neomycin (CAS 119-04-0) Sales by Country (2016-2021e) & (Kg)
Table 57. North America Neomycin (CAS 119-04-0) Sales by Country (2021-2026) & (Kg)
Table 58. North America Neomycin (CAS 119-04-0) Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Neomycin (CAS 119-04-0) Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Neomycin (CAS 119-04-0) Sales by Type (2016-2021e) & (Kg)
Table 61. North America Neomycin (CAS 119-04-0) Sales by Type (2021-2026) & (Kg)
Table 62. North America Neomycin (CAS 119-04-0) Sales by Application (2016-2021e) & (Kg)
Table 63. North America Neomycin (CAS 119-04-0) Sales by Application (2021-2026) & (Kg)
Table 64. Europe Neomycin (CAS 119-04-0) Sales by Country (2016-2021e) & (Kg)
Table 65. Europe Neomycin (CAS 119-04-0) Sales by Country (2021-2026) & (Kg)
Table 66. Europe Neomycin (CAS 119-04-0) Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Neomycin (CAS 119-04-0) Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Neomycin (CAS 119-04-0) Sales by Type (2016-2021e) & (Kg)
Table 69. Europe Neomycin (CAS 119-04-0) Sales by Type (2021-2026) & (Kg)
Table 70. Europe Neomycin (CAS 119-04-0) Sales by Application (2016-2021e) & (Kg)
Table 71. Europe Neomycin (CAS 119-04-0) Sales by Application (2021-2026) & (Kg)
Table 72. Asia-Pacific Neomycin (CAS 119-04-0) Sales by Region (2016-2021e) & (Kg)
Table 73. Asia-Pacific Neomycin (CAS 119-04-0) Sales by Region (2021-2026) & (Kg)
Table 74. Asia-Pacific Neomycin (CAS 119-04-0) Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Neomycin (CAS 119-04-0) Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Neomycin (CAS 119-04-0) Sales by Type (2016-2021e) & (Kg)
Table 77. Asia-Pacific Neomycin (CAS 119-04-0) Sales by Type (2021-2026) & (Kg)
Table 78. Asia-Pacific Neomycin (CAS 119-04-0) Sales by Application (2016-2021e) & (Kg)
Table 79. Asia-Pacific Neomycin (CAS 119-04-0) Sales by Application (2021-2026) & (Kg)
Table 80. South America Neomycin (CAS 119-04-0) Sales by Country (2016-2021e) & (Kg)
Table 81. South America Neomycin (CAS 119-04-0) Sales by Country (2021-2026) & (Kg)
Table 82. South America Neomycin (CAS 119-04-0) Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Neomycin (CAS 119-04-0) Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Neomycin (CAS 119-04-0) Sales by Type (2016-2021e) & (Kg)
Table 85. South America Neomycin (CAS 119-04-0) Sales by Type (2021-2026) & (Kg)
Table 86. South America Neomycin (CAS 119-04-0) Sales by Application (2016-2021e) & (Kg)
Table 87. South America Neomycin (CAS 119-04-0) Sales by Application (2021-2026) & (Kg)
Table 88. Middle East & Africa Neomycin (CAS 119-04-0) Sales by Country (2016-2021e) & (Kg)
Table 89. Middle East & Africa Neomycin (CAS 119-04-0) Sales by Country (2021-2026) & (Kg)
Table 90. Middle East & Africa Neomycin (CAS 119-04-0) Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Neomycin (CAS 119-04-0) Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Neomycin (CAS 119-04-0) Sales by Type (2016-2021e) & (Kg)
Table 93. Middle East & Africa Neomycin (CAS 119-04-0) Sales by Type (2021-2026) & (Kg)
Table 94. Middle East & Africa Neomycin (CAS 119-04-0) Sales by Application (2016-2021e) & (Kg)
Table 95. Middle East & Africa Neomycin (CAS 119-04-0) Sales by Application (2021-2026) & (Kg)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Neomycin (CAS 119-04-0) Typical Distributors
Table 99. Neomycin (CAS 119-04-0) Typical Customers
List of Figures
Figure 1. Neomycin (CAS 119-04-0) Picture
Figure 2. Global Neomycin (CAS 119-04-0) Sales Market Share by Type in 2020
Figure 3. 98% Purity Type
Figure 4. 95% Purity Type
Figure 5. Others
Figure 6. Global Neomycin (CAS 119-04-0) Sales Market Share by Application in 2020
Figure 7. Neomycin Sulfate Eye Drops
Figure 8. Neomycin Sulfate Tablets
Figure 9. Compound Neomycin Ointment
Figure 10. Global Neomycin (CAS 119-04-0) Market Size, (USD Million) & (Kg): 2020 VS 2021 VS 2026
Figure 11. Global Neomycin (CAS 119-04-0) Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Neomycin (CAS 119-04-0) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Neomycin (CAS 119-04-0) Sales (2016-2026) & (Kg)
Figure 32. Global Neomycin (CAS 119-04-0) Production Capacity (2016-2026) & (Kg)
Figure 33. Global Neomycin (CAS 119-04-0) Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Neomycin (CAS 119-04-0) Market Drivers
Figure 35. Neomycin (CAS 119-04-0) Market Restraints
Figure 36. Neomycin (CAS 119-04-0) Market Trends
Figure 37. Global Neomycin (CAS 119-04-0) Sales Market Share by Manufacturer in 2020
Figure 38. Global Neomycin (CAS 119-04-0) Revenue Market Share by Manufacturer in 2020
Figure 39. Neomycin (CAS 119-04-0) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Neomycin (CAS 119-04-0) Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Neomycin (CAS 119-04-0) Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Neomycin (CAS 119-04-0) Sales Market Share by Region (2016-2026)
Figure 43. Global Neomycin (CAS 119-04-0) Revenue Market Share by Region (2016-2026)
Figure 44. North America Neomycin (CAS 119-04-0) Revenue (2016-2026) & (USD Million)
Figure 45. Europe Neomycin (CAS 119-04-0) Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Neomycin (CAS 119-04-0) Revenue (2016-2026) & (USD Million)
Figure 47. South America Neomycin (CAS 119-04-0) Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Neomycin (CAS 119-04-0) Revenue (2016-2026) & (USD Million)
Figure 49. Global Neomycin (CAS 119-04-0) Sales Market Share by Type (2016-2026)
Figure 50. Global Neomycin (CAS 119-04-0) Revenue Market Share by Type (2016-2026)
Figure 51. Global Neomycin (CAS 119-04-0) Price by Type (2016-2026) & (USD/Kg)
Figure 52. Global Neomycin (CAS 119-04-0) Sales Market Share by Application (2016-2026)
Figure 53. Global Neomycin (CAS 119-04-0) Revenue Market Share by Application (2016-2026)
Figure 54. Global Neomycin (CAS 119-04-0) Price by Application (2016-2026) & (USD/Kg)
Figure 55. North America Neomycin (CAS 119-04-0) Sales Market Share by Country (2016-2026)
Figure 56. North America Neomycin (CAS 119-04-0) Revenue Market Share by Country (2016-2026)
Figure 57. North America Neomycin (CAS 119-04-0) Sales Market Share by Type (2016-2026)
Figure 58. North America Neomycin (CAS 119-04-0) Sales Market Share by Application (2016-2026)
Figure 59. Europe Neomycin (CAS 119-04-0) Sales Market Share by Country (2016-2026)
Figure 60. Europe Neomycin (CAS 119-04-0) Revenue Market Share by Country (2016-2026)
Figure 61. Europe Neomycin (CAS 119-04-0) Sales Market Share by Type (2016-2026)
Figure 62. Europe Neomycin (CAS 119-04-0) Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Neomycin (CAS 119-04-0) Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Neomycin (CAS 119-04-0) Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Neomycin (CAS 119-04-0) Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Neomycin (CAS 119-04-0) Sales Market Share by Application (2016-2026)
Figure 67. South America Neomycin (CAS 119-04-0) Sales Market Share by Country (2016-2026)
Figure 68. South America Neomycin (CAS 119-04-0) Revenue Market Share by Country (2016-2026)
Figure 69. South America Neomycin (CAS 119-04-0) Sales Market Share by Type (2016-2026)
Figure 70. South America Neomycin (CAS 119-04-0) Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Neomycin (CAS 119-04-0) Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Neomycin (CAS 119-04-0) Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Neomycin (CAS 119-04-0) Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Neomycin (CAS 119-04-0) Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
肝性脳症（HE）治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 HE is a potentially fatal brain disorder that is caused by liver damage, which results in the failure to remove toxins from the blood. Scope of the Report: This report focuses on the Hepatic Encephalopathy (HE) Therapeutics in global market, especially in North America, Europe and Asia-Pacific, Sout…- アミノグリコシドの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial therapeutic agents that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside (sugar); the term can also refer more generally to any organic molecule that cont…
- 世界のゲンタマイシン硫酸塩市場 2021：企業別、地域別、種類・用途別 The Gentamycin Sulfate (CAS 1405-41-0) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界のイマザリル硫酸塩市場 2021：企業別、地域別、種類・用途別 The Imazalil Sulfate (CAS 60534-80-7) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 世界の硫酸シソミシン市場 2021：企業別、地域別、種類・用途別 The Sisomicin Sulfate (CAS 53179-09-2) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…